RARE
Ultragenyx to Host Conference Call for Second Quarter 2022 Financial Results and Corporate Update
Monday, July 25, 2022 BiopharmaWatch Research 1 min read Key Takeaway: Ultragenyx to Host Conference Call for Second Quarter 2022 Financial Results and Corporate Update
Price reaction · baseline $51.49 (2022-07-22 close) · 2 other RARE headline(s) in the window, move may be shared
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+43%
120-day peak, hindsight
Typical move
2.9%
average across 6 past catalysts
Cash runway
~13 mo
Low dilution risk
Lead asset
BPS804
Phase 2 · Hypophosphatasia
Full Press Release Details
Ultragenyx to Host Conference Call for Second Quarter 2022 Financial Results and Corporate Update.